Publications by Dr Jeremy Palmer - ePrints

Browsing publications by Dr Jeremy Palmer.

Newcastle Authors	Title	Year
Raya Vinogradov Dr Oisín Kavanagh Dr Jeremy Palmer Dr Emma Curtis Professor Farhad Kamali et al.	A randomized crossover design study comparing the pharmacokinetics and pharmacodynamics of 2 single doses of oral aspirin (75 mg v 150 mg) in pregnant women at risk of preeclampsia: implications on assessing aspirin response and patient adherence to therapy	2024
Dr Min Cao Dr Alison Day Dr Martin Galler Heather Latimer Tom Foy et al.	A peroxiredoxin-P38 MAPK scaffold increases MAPK activity by MAP3K-independent mechanisms	2023
Lucy Gee Dr Ben Barron-Millar Dr Marco Zaki Dr Saimir Luli Rachel Burgoyne et al.	Anti–Cholestatic Therapy with Obeticholic Acid Improves Short-Term Memory in Bile Duct–Ligated Mice	2023
Dr Olivier Govaere Dr Rebecca Darlay Dr Julien Peltier Dr Jeremy Palmer Dr Massimo Younes et al.	Macrophage Scavenger Receptor 1 mediates lipid-induced inflammation in non-alcoholic fatty liver disease	2022
Dr Aaron Wetten Dr Laura Ogle Dr George Mells Dr Vinod Hegade Dr Laura Jopson et al.	Neurosteroid Activation of GABA-A Receptors: A Potential Treatment Target for Symptoms in Primary Biliary Cholangitis?	2022
Dr Sam Tingle Dr Emily Thompson Lucy Bates Dr Ibrahim Ibrahim Dr Olivier Govaere et al.	Pharmacological testing of therapeutics using normothermic machine perfusion: A pilot study of 2,4-dinitrophenol delivery to steatotic human livers	2022
Dr Claire Granger Professor Chris Lamb Professor Nicholas Embleton Lauren Beck Andrea Masi et al.	sIgA in preterm infants: determination of normal values in breast milk and stool	2022
Professor David Jones Dr Aaron Wetten Dr Ben Barron-Millar Dr Laura Ogle Dr George Mells et al.	The relationship between disease activity and UDCA response criteria in primary biliary cholangitis: A cohort study	2022
Dr Claire Granger Professor Nicholas Embleton Dr Jeremy Palmer Professor Chris Lamb Professor Janet Berrington et al.	Maternal breastmilk, infant gut microbiome and the impact on preterm infant health	2021
Dr Alistair Leitch Dr Ibrahim Ibrahim Dr Tarek Mamdouh Abdelghany Dr Alex Charlton Clair Roper et al.	The methylimidazolium ionic liquid M8OI is detectable in human sera and is subject to biliary excretion in perfused human liver	2021
Dr Ben Barron-Millar Dr Laura Ogle Emeritus Professor John Kirby Dr Jeremy Palmer Dr Laura Jopson et al.	The Serum Proteome and Ursodeoxycholic Acid Response in Primary Biliary Cholangitis	2021
Professor Quentin Anstee Dr Rebecca Darlay Dr Simon Cockell Dr Olivier Govaere Dr Dina Tiniakos et al.	Genome-Wide Association Study of Non-Alcoholic Fatty Liver and Steatohepatitis in a Histologically-Characterised Cohort	2020
Dr Alistair Leitch Dr Tarek Mamdouh Abdelghany Dr Phillip Probert Dr Stephanie Meyer Dr Jeremy Palmer et al.	The toxicity of the methylimidazolium ionic liquids, with a focus on M8OI and hepatic effects	2020
Dr Olivier Govaere Dr Simon Cockell Dr Dina Tiniakos Dr Rachel Queen Dr Massimo Younes et al.	Transcriptomic profiling across the nonalcoholic fatty liver disease spectrum reveals gene signatures for steatohepatitis and fibrosis	2020
Dr Phillip Probert Dr Alistair Leitch Dr Michael Dunn Dr Stephanie Meyer Dr Jeremy Palmer et al.	Identification of a xenobiotic as a potential environmental trigger in primary biliary cholangitis	2018
Dr Emma Scott Dr Jeremy Palmer Professor Quentin Anstee	Impaired hepatic lipid synthesis from polyunsaturated fatty acids in TM6SF2 E167K variant carriers with NAFLD	2017
Dr Phillip Probert Dr Jeremy Palmer Dr Aimen Amer Steven White Professor David Jones et al.	Progenitor-derived hepatocyte-like (B-13/H) cells metabolise 1′-hydroxyestragole to a genotoxic species via a SULT2B1-dependent mechanism	2016
Dr Jess Dyson Dr Jeremy Palmer Dr Lin Lee Wong Dr Stuart Kendrick Professor David Jones et al.	Understanding the importance of pro- and anti-inflammatory cytokines in autoimmune hepatitis	2016
Dr Edwin Wong Dr Jeremy Palmer Professor Neil Sheerin Dr Isabel Pappworth	FH1-5^(18-20) ameliorates experimental C3 glomerulopathy; generation and testing of a murine version for further pre-clinical experiments	2015
Dr Jeremy Palmer Dr Yang-Lin Liu Professor Chris Day Professor Ann Daly Professor Quentin Anstee et al.	Mechanistic Study of TM6SF2 in NAFLD pathogenesis: Stably transfected Huh7 cells over-expressing the TM6SF2 E167K variant exhibit greater levels of oxidative stress	2015
Dr Laura Jopson Emerita Professor Julia Newton Dr Jeremy Palmer Achilleas FLOUDAS Professor John Isaacs et al.	RITPBC: B-Cell Depleting Therapy (rituximab) as a treatment for fatigue in Primary Biliary Cirrhosis: study protocol for a randomised controlled trial	2015
Dr Laura Jopson Emerita Professor Julia Newton Denise Howel Dr Jeremy Palmer Professor John Isaacs et al.	RITPBC: B-cell depleting therapy (RITUXIMAB) as a treatment for fatigue in primary biliary cirrhosis: study protocol for a randomised controlled trial	2015
Dr Jeremy Palmer Professor David Jones Dr Jess Dyson Emeritus Professor John Kirby	Understanding the Mechanisms Underpinning Treatment Non-Response in Primary Biliary Cirrhosis: A Tool for Treatment Stratification	2014
Dr Jeremy Palmer Dr Jess Dyson Professor David Jones Emeritus Professor John Kirby	Understanding the mechanisms underpinning treatment non-response in Primary Biliary Cirrhosis: a tool for treatment stratification	2014
Achilleas FLOUDAS Dr Laura Jopson Dacia Jones Dr Andrew Knight Dr Jeremy Palmer et al.	Altered B cell populations and cytokine production in primary biliary cirrhosis	2013
Greta Pells Samantha Ducker Dr Jeremy Palmer Emerita Professor Julia Newton Dacia Jones et al.	Patient Impact of Inflammation in Primary Biliary Cirrhosis (PBC): Inflammatory Cytokine Levels are Elevated but Unrelated to Fatigue Severity	2013
Dr Jeremy Palmer Professor Farhad Kamali	Quality of bevacizumab compounded for intravitreal administration	2013
Dr Graeme O'Boyle Christopher Fox Dr Hannah Walden Dr Joe Willet Dr Emily Mavin et al.	Chemokine receptor CXCR3 agonist prevents human T-cell migration in a humanized model of arthritic inflammation	2012
Dr Jeremy Palmer Dr Andrew Knight Professor Kevin Marchbank	A novel chimeric antigen hC3d-TTCF-hC4BP interacts with mCR2 allowing extensive testing as a novel adjuvant using murine models	2010
Dr Stuart Kendrick Dr Graeme O'Boyle Professor Jelena Mann Dr Mujdat Zeybel Dr Jeremy Palmer et al.	Acetate, the Key Modulator of Inflammatory Responses in Acute Alcoholic Hepatitis	2010
Dr Jeremy Palmer Dr Imran Patanwala Elsbeth Henderson Professor Chris Day Professor David Jones et al.	Allo- and auto-antibody responses in ALD as biomarkers of prognosis	2010
Dr Stuart Kendrick Elsbeth Henderson Dr Jeremy Palmer Professor David Jones Professor Chris Day et al.	Theophylline improves steroid sensitivity in acute alcoholic hepatitis	2010
Dr Jeremy Palmer Dr Hannah Walden Emeritus Professor John Kirby Professor David Jones	680: Incorporation of 6-bromohexanoic acid (6BH) into cellular pyruvate dehydrogenase complex (PDC): Further evidence for generation of an autoimmunogenic neoantigen in primary billary cirrhosis (PBC)	2009
Dr Stuart Kendrick Dr Graeme O'Boyle Dr Jeremy Palmer Professor David Jones	Enhanced inflammatory responses in alcoholic liver disease: is acetate the key?	2008
Dr Jeremy Palmer Professor David Jones Emeritus Professor John Kirby	Human Th17 cells: investigation of T cell differentiation in the presence of TGF-beta and a range of pro-inflammatory cytokines	2008
Emerita Professor Julia Newton Dr Kieren Hollingsworth Dr Jeremy Palmer Professor Roy Taylor Professor Andrew Blamire et al.	Mitochondrial dysfunction and muscle PH abnormality post-exercise: A two-hit mechanism for fatigue pathogenesis in primary biliary cirrhosis	2008
Dr Kieren Hollingsworth Emerita Professor Julia Newton Professor Roy Taylor Dr Claire McDonald Dr Jeremy Palmer et al.	Pilot Study of Peripheral Muscle Function in Primary Biliary Cirrhosis: Potential Implications for Fatigue Pathogenesis	2008
Professor David Jones Dr Jeremy Palmer Professor Alastair Burt Emeritus Professor John Kirby	The specificity of liver inflammation in mouse models of primary biliary cirrhosis	2008
Dr Hannah Walden Emeritus Professor John Kirby Emeritus Professor Steve Yeaman Dr Joseph Gray Professor David Jones et al.	Xenobiotic Incorporation into Pyruvate Dehydrogenase Complex Can Occur Via the Exogenous Lipoylation Pathway	2008
Dr Stuart Kendrick Dr Jeremy Palmer Professor David Jones Professor Chris Day	Lymphocyte steroid sensitivity in severe alcoholic hepatitis	2007
Dr Hannah Walden Dr Jeremy Palmer Emeritus Professor John Kirby Dr Stuart Kendrick Professor David Jones et al.	Substrate promiscuity in the pyruvate dehydrogenase complex (PDC) lipoylation pathway: Xenobiotic incorporation as a potential mechanism for the pathogenesis of primary biliary cirrhosis (PBC)	2007
Professor David Jones Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby	Adoptive transfer of self-PDC reactive T-cells into naive mice induces portal tract and bile duct changes characteristic of primary biliary cirrhosis (PBC)	2006
Dr Amanda Greenall Katherine Martin Dr Jeremy Palmer Dr Joseph Gray Dr Simon Whitehall et al.	Hip3 interacts with the HIRA proteins Hip1 and Slm9 and is required for transcriptional silencing and accurate chromosome segregation	2006
Anna McHugh Dr Amanda Robe Dr Jeremy Palmer Professor David Jones	PDC-E3BP is not a dominant T-cell autoantigen in primary biliary cirrhosis	2006
Dr Amanda Robe Emeritus Professor John Kirby Professor David Jones Dr Jeremy Palmer	A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse	2005
Dr Amanda Robe Emeritus Professor John Kirby Professor David Jones Dr Jeremy Palmer	A key role for autoreactive B cells in the breakdown of T-cell tolerance to pyruvate dehydrogenase complex in the mouse	2005
Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones	Apoptosis as a mechanism for cell surface expression of the autoantigen pyruvate dehydrogenase complex	2004
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones	Breakdown of T-cell tolerance to the primary biliary cirrhosis (PBC) autoantigen pyruvate dehydrogenase complex is a B-cell driven process	2004
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones	Breakdown of T-cell tolerance to the primary biliary cirrhosis (PBC) autoantigen pyruvate dehydrogenase complex is a B-cell driven process	2004
Dr Jeremy Palmer Dr Amanda Robe Professor Alastair Burt Emeritus Professor John Kirby Professor David Jones et al.	Covalent modification as a mechanism for the breakdown of immune tolerance to pyruvate dehydrogenase complex in the mouse	2004
Anna McHugh Dr Jeremy Palmer Emeritus Professor Steve Yeaman Professor David Jones	Is PDC-E3BP (protein X) a T-cell autoantigen in primary biliary cirrhosis?	2003
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor Margaret Bassendine Professor David Jones et al.	[abstract] Characterisation of liver infiltrating T-cell antigen specificity in a mouse model of primary biliary cirrhosis (PBC)	2002
Professor David Jones Dr Jeremy Palmer Professor Alastair Burt Dr Amanda Robe Emeritus Professor John Kirby et al.	Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex	2002
Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones	Breakdown of tolerance is seen to both PDC-E2 and PDC-E3BP, individual antigens in primary biliary cirrhosis, in a mouse model of PDC autoreactivity	2002
Dr Amanda Robe Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones	Characterisation of liver infiltrating T-cell antigen specificity in a mouse model of primary biliary cirrhosis (PBC)	2002
Professor David Jones Dr Jeremy Palmer Dr Amanda Robe Emeritus Professor John Kirby	Oral tolerisation to pyruvate dehydrogenase complex as a potential therapy for primary biliary cirrhosis	2002
Dr Jeremy Palmer Emeritus Professor John Kirby Professor David Jones	The immunology of primary biliary cirrhosis: The end of the beginning?	2002
Dr Jeremy Palmer Emeritus Professor Steve Yeaman Professor David Jones	Epitope specificity of anti-PDC E1 alpha antibodies in primary biliary cirrhosis (PBC)	2001
Dr Jeremy Palmer Emeritus Professor John Kirby Emeritus Professor Steve Yeaman Professor Margaret Bassendine Professor David Jones et al.	Secretory autoantibodies in primary biliary cirrhosis (PBC)	2000
Dr Jeremy Palmer Professor David Jones Professor Janet Quinn Anna McHugh Emeritus Professor Steve Yeaman et al.	Characterization of the autoantibody responses to recombinant E3 binding protein (protein X) of pyruvate dehydrogenase in primary biliary cirrhosis	1999
Marian Case Professor Alastair Burt Joan Hughes Dr Jeremy Palmer Professor Margaret Bassendine et al.	Erratum to 'Enhanced ultrasensitive detection of structurally diverse antigens using a single immuno-PCR assay protocol' (Journal of Immunological Methods (1999) 223 (93-106))	1999
Dr Jeremy Palmer Emeritus Professor John Kirby Emeritus Professor Steve Yeaman Professor David Jones	Persistence of secretory autoantibodies in PBC patients post-liver transplant: a potential mechanism for disease recurrence?	1999
Dr Jeremy Palmer Emeritus Professor Steve Yeaman Professor Margaret Bassendine Professor David Jones	T cell responses to the putative dominant autoepitope in primary biliary cirrhosis (PBC)	1999
Dr Ian Brotherick Dr Brian Shenton Emeritus Professor John Kirby Dr Jeremy Palmer Emeritus Professor Steve Yeaman et al.	Production of immunosuppressive factors by a cultured tumor cell line and their effect on lymphocyte proliferation and cells cycle response	1993